Seaport Therapeutics SPTX Deferred Offering Costs Included In Accounts Payable And Accrued Expenses
Other financials
Where this comes from
Reported directly by Seaport Therapeutics in its filing.
Tagged under the XBRL concept sptx:DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses.
The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Seaport Therapeutics 's deferred offering costs included in accounts payable and accrued expenses.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Seaport Therapeutics 's deferred offering costs included in accounts payable and accrued expenses?
- Seaport Therapeutics (SPTX) reported deferred offering costs included in accounts payable and accrued expenses of $541K in Q1 2026.